Mechanism of metastasis suppression by luteolin in breast cancer

References

• SiegelRLMillerKDJemalACancer statistics, 2017CA Cancer J Clin201767173028055103
   PubMed Web of Science ®Google Scholar
• PagetSThe distribution of secondary growths in cancer of the breastLancet18891333421571573
   Google Scholar
• GuptaGPMassaguéJCancer metastasis: building a frameworkCell2006127467969517110329
   PubMed Web of Science ®Google Scholar
• SteegPSTumor metastasis: mechanistic insights and clinical challengesNat Med200612889590416892035
   PubMed Web of Science ®Google Scholar
• FidlerIJThe pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisitedNat Rev Cancer20033645345812778135
   PubMed Web of Science ®Google Scholar
• WeigeltBPeterseJLVan’t VeerLJBreast cancer metastasis: markers and modelsNat Rev Cancer20055859116056258
   PubMed Web of Science ®Google Scholar
• Lopez-LazaroMDistribution and biological activities of the flavonoid luteolinMini Rev Med Chem200991315919149659
   PubMed Web of Science ®Google Scholar
• HanahanDWeinbergRAHallmarks of cancer: the next generationCell2011144564667421376230
   PubMed Web of Science ®Google Scholar
• PriceDJMiralemTJiangSSteinbergRAvrahamHRole of vascular endothelial growth factor in the stimulation of cellular invasion and signaling of breast cancer cellsCell Growth Differ200112312913511306513
   PubMedGoogle Scholar
• FerraraNGerberHPLeCouterJThe biology of VEGF and its receptorsNat Med20039666967612778165
   PubMed Web of Science ®Google Scholar
• HanahanDFolkmanJPatterns and emerging mechanisms of the angiogenic switch during tumorigenesisCell19968633533648756718
   PubMed Web of Science ®Google Scholar
• HicklinDJEllisLMRole of the vascular endothelial growth factor pathway in tumor growth and angiogenesisJ Clin Oncol20052351011102715585754
   PubMed Web of Science ®Google Scholar
• ZhaoDPanCSunJVEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2Oncogene201534243107311925151964
   PubMed Web of Science ®Google Scholar
• CookMTLiangYBesch-WillifordCHyderSMLuteolin inhibits lung metastasis, cell migration, and viability of triple-negative breast cancer cellsBreast Cancer (Dove Med Press)2017991928096694
   PubMed Web of Science ®Google Scholar
• SunDWZhangHDMaoLLuteolin inhibits breast cancer development and progression in vitro and in vivo by suppressing notch signaling and regulating miRNAsCell Physiol Biochem20153751693171126545287
   PubMedGoogle Scholar
• CookMTLiangYBesch-WillifordCGoyetteSMafuvadzeBHyderSMLuteolin inhibits progestin-dependent angiogenesis, stem cell-like characteristics, and growth of human breast cancer xenograftsSpringerPlus2015444426312209
   PubMedGoogle Scholar
• PratheeshkumarPSonYOBudhrajaALuteolin inhibits human prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesisPLoS One2013712e52279
   Web of Science ®Google Scholar
• LinDKuangGWanJLuteolin suppresses the metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via downregulation of β-catenin expressionOncol Rep201737289590227959422
   PubMed Web of Science ®Google Scholar
• ZangMHuLZhangBLuteolin suppresses angiogenesis and vasculogenic mimicry formation through inhibiting Notch1-VEGF signaling in gastric cancerBiochem Biophys Res Commun2017490391391928655612
   PubMed Web of Science ®Google Scholar
• BagliEStefaniotouMMorbidelliLLuteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3′-kinase activityCancer Res200464217936794615520200
   PubMed Web of Science ®Google Scholar
• RavishankarDWatsonKABoatengSYGreenRJGrecoFOsbornHMExploring quercetin and luteolin derivatives as antiangiogenic agentsEur J Med Chem20159725927425984842
   PubMed Web of Science ®Google Scholar
• ZhuMChenDLiDLuteolin inhibits angiotensin II-induced human umbilical vein endothelial cell proliferation and migration through downregulation of Src and Akt phosphorylationCirc J201377377277923171663
   PubMed Web of Science ®Google Scholar
• HiraokaNAllenEApelIJGyetkoMRWeissSJMatrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysinsCell19989533653779814707
   PubMed Web of Science ®Google Scholar
• DeryuginaEIQuigleyJPMatrix metalloproteinases and tumor metastasisCancer Metastasis Rev200625193416680569
   PubMed Web of Science ®Google Scholar
• MerdadAKarimSSchultenHJExpression of matrix metalloproteinases (MMPs) in primary human breast cancer: MMP-9 as a potential biomarker for cancer invasion and metastasisAnticancer Res20143431355136624596383
   PubMed Web of Science ®Google Scholar
• EndeCGebhardtRInhibition of matrix metalloproteinase-2 and-9 activities by selected flavonoidsPlanta Med200470101006100815490332
   PubMed Web of Science ®Google Scholar
• ParkSHKimJHLeeDHLuteolin 8-C-β-fucopyranoside inhibits invasion and suppresses TPA-induced MMP-9 and IL-8 via ERK/AP-1 and ERK/NF-κB signaling in MCF-7 breast cancer cellsBiochimie201395112082209023933110
   PubMed Web of Science ®Google Scholar
• VandoorenJvan den SteenPEOpdenakkerGBiochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decadeCrit Rev Biochem Mol Biol201348322227223547785
   PubMed Web of Science ®Google Scholar
• JiangYXieKHuoHWangLZouWXieMInhibitory effect of luteolin on the angiogenesis of chick chorioallantoic membrane and invasion of breast cancer cells via downregulation of AEG-1 and MMP-2Sheng Li Xue Bao2013655513518 Chinese24129732
   PubMedGoogle Scholar
• LuXLiYXiaoXLiXInhibitory effects of luteolin on human gastric carcinoma xenografts in nude mice and its mechanismZhonghua Yi Xue Za Zhi2013932142146 Chinese23648354
   PubMedGoogle Scholar
• PanduranganADharmalingamPSadagopanSGanapasamSLuteolin inhibits matrix metalloproteinase 9 and 2 in azoxymethane-induced colon carcinogenesisHum Exp Toxicol201433111176118524532706
   PubMed Web of Science ®Google Scholar
• HuangXDaiSDaiJLuteolin decreases invasiveness, deactivates STAT3 signaling, and reverses interleukin-6 induced epithelial–mesenchymal transition and matrix metalloproteinase secretion of pancreatic cancer cellsOnco Targets Ther20158298926527884
   PubMed Web of Science ®Google Scholar
• KöhrmannAKammererUKappMDietlJAnackerJExpression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literatureBMC Cancer2009918819531263
   PubMed Web of Science ®Google Scholar
• TurleyEANoblePWBourguignonLYSignaling properties of hyaluronan receptorsJ Biol Chem200227774589459211717317
   PubMed Web of Science ®Google Scholar
• SheridanCKishimotoHFuchsRKCD44+/CD24-breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasisBreast Cancer Res200685R5917062128
   PubMed Web of Science ®Google Scholar
• Charafe-JauffretEGinestierCIovinoFBreast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signatureCancer Res20096941302131319190339
   PubMed Web of Science ®Google Scholar
• DraffinJEMcFarlaneSHillAJohnstonPGWaughDJCD44 potentiates the adherence of metastatic prostate and breast cancer cells to bone marrow endothelial cellsCancer Res200464165702571115313910
   PubMed Web of Science ®Google Scholar
• KuppusamyUKhooHDasNStructure-activity studies of flavonoids as inhibitors of hyaluronidaseBiochem Pharmacol19904023974012375774
   PubMed Web of Science ®Google Scholar
• ReipasKMLawJHCoutoNLuteolin is a novel p90 ribosomal S6 kinase (RSK) inhibitor that suppresses Notch4 signaling by blocking the activation of Y-box binding protein-1 (YB-1)Oncotarget20134232934523593654
   PubMedGoogle Scholar
• TsaiPHChengCHLinCYDietary flavonoids luteolin and quercetin suppressed cancer stem cell properties and metastatic potential of isolated prostate cancer cellsAnticancer Res201636126367638027919958
   PubMed Web of Science ®Google Scholar
• TuDGLinWTYuCCChemotherapeutic effects of luteolin on radio-sensitivity enhancement and interleukin-6/signal transducer and activator of transcription 3 signaling repression of oral cancer stem cellsJ Formos Med Assoc2016115121032103827742160
   PubMed Web of Science ®Google Scholar
• HojillaCMohammedFKhokhaRMatrix metalloproteinases and their tissue inhibitors direct cell fate during cancer developmentBr J Cancer200389101817182114612884
   PubMed Web of Science ®Google Scholar
• KorkayaHLiuSWichaMSBreast cancer stem cells, cytokine networks, and the tumor microenvironmentJ Clin Invest2011121103804380921965337
   PubMed Web of Science ®Google Scholar
• SeelingerGMerfortISchemppCMAnti-oxidant, anti-inflammatory and anti-allergic activities of luteolinPlanta Med200874141667167718937165
   PubMed Web of Science ®Google Scholar
• BenoyIHSalgadoRvan DamPIncreased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survivalClin Cancer Res200410217157716215534087
   PubMed Web of Science ®Google Scholar
• ChoiHJChoiHJChungTWHaKTLuteolin inhibits recruitment of monocytes and migration of Lewis lung carcinoma cells by suppressing chemokine (C–C motif) ligand 2 expression in tumor-associated macrophageBiochem Biophys Res Commun2016470110110626766793
   PubMed Web of Science ®Google Scholar
• ZhanTRindtorffNBoutrosMWnt signaling in cancerOncogene201736111461147327617575
   PubMed Web of Science ®Google Scholar
• LamouilleSXuJDerynckRMolecular mechanisms of epithelial–mesenchymal transitionNat Rev Mol Cell Biol201415317819624556840
   PubMed Web of Science ®Google Scholar
• TseJCKalluriRMechanisms of metastasis: epithelial-to-mesenchymal transition and contribution of tumor microenvironmentJ Cell Biochem2007101481682917243120
   PubMed Web of Science ®Google Scholar
• NelsonWJNusseRConvergence of Wnt, β-catenin, and cadherin pathwaysScience200430356631483148715001769
   PubMed Web of Science ®Google Scholar
• CleversHWnt/β-catenin signaling in development and diseaseCell2006127346948017081971
   PubMed Web of Science ®Google Scholar
• BlancoMJMoreno-BuenoGSarrioDCorrelation of Snail expression with histological grade and lymph node status in breast carcinomasOncogene200221203241324612082640
   PubMed Web of Science ®Google Scholar
• PanduranganAKDharmalingamPSadagopanSKARamarMMunusamyAGanapasamSLuteolin induces growth arrest in colon cancer cells through involvement of Wnt/β-catenin/GSK-3β signalingJ Environ Pathol Toxicol Oncol201332213113924099426
   PubMed Web of Science ®Google Scholar
• ChenJImanakaNGriffinJHypoxia potentiates Notch signaling in breast cancer leading to decreased E-cadherin expression and increased cell migration and invasionBr J Cancer2010102235136020010940
   PubMed Web of Science ®Google Scholar
• RanganathanPWeaverKLCapobiancoAJNotch signalling in solid tumours: a little bit of everything but not all the timeNat Rev Cancer201111533835121508972
   PubMed Web of Science ®Google Scholar
• AnjumRBlenisJThe RSK family of kinases: emerging roles in cellular signallingNat Rev Mol Cell Biol200891074775818813292
   PubMed Web of Science ®Google Scholar
• HarrisonHFarnieGHowellSJRegulation of breast cancer stem cell activity by signaling through the Notch4 receptorCancer Res201070270971820068161
   PubMed Web of Science ®Google Scholar
• EspinosaLInglés-EsteveJAguileraCBigasAPhosphorylation by glycogen synthase kinase-3β down-regulates Notch activity, a link for Notch and Wnt pathwaysJ Biol Chem200327834322273223512794074
   PubMed Web of Science ®Google Scholar
• FangXYuSXLuYBastRCWoodgettJRMillsGBPhosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase AProc Natl Acad Sci U S A20009722119601196511035810
   PubMed Web of Science ®Google Scholar
• MalumbresMBarbacidMCell cycle, CDKs and cancer: a changing paradigmNat Rev Cancer20099315316619238148
   PubMed Web of Science ®Google Scholar
• LeeEJOhSYSungMKLuteolin exerts anti-tumor activity through the suppression of epidermal growth factor receptor-mediated pathway in MDA-MB-231 ER-negative breast cancer cellsFood Chem Toxicol201250114136414322926442
   PubMed Web of Science ®Google Scholar
• RaoPSSatelliAMoridaniMJenkinsMRaoUSLuteolin induces apoptosis in multidrug resistant cancer cells without affecting the drug transporter function: involvement of cell line-specific apoptotic mechanismsInt J Cancer2012130112703271421792893
   PubMed Web of Science ®Google Scholar
• ChiangCTWayTDLinJKSensitizing HER2-overexpressing cancer cells to luteolin-induced apoptosis through suppressing p21WAF1/CIP1 expression with rapamycinMol Cancer Ther2007672127213817620442
   PubMed Web of Science ®Google Scholar
• AbbasTDuttaAP21 in cancer: intricate networks and multiple activitiesNat Rev Cancer20099640041419440234
   PubMed Web of Science ®Google Scholar
• CasagrandeFDarbonJMEffects of structurally related flavonoids on cell cycle progression of human melanoma cells: regulation of cyclin-dependent kinases CDK2 and CDK1Biochem Pharmacol200161101205121511322924
   PubMed Web of Science ®Google Scholar
• ChowdhuryARSharmaSMandalSGoswamiAMukhopadhyaySMajumderHKLuteolin, an emerging anti-cancer flavonoid, poisons eukaryotic DNA topoisomerase IBiochem J2002366265366112027807
   PubMed Web of Science ®Google Scholar
• YamashitaNKawanishiSDistinct mechanisms of DNA damage in apoptosis induced by quercetin and luteolinFree Radic Res200033562363311200093
   PubMed Web of Science ®Google Scholar
• AminARWangDZhangHEnhanced anti-tumor activity by the combination of the natural compounds (−)-epigallocatechin-3-gallate and luteolin potential role of p53J Biol Chem201028545345573456520826787
   PubMed Web of Science ®Google Scholar
• OvertonKWSpencerSLNodererWLMeyerTWangCLBasal p21 controls population heterogeneity in cycling and quiescent cell cycle statesProc Natl Acad Sci U S A201411141E4386E439325267623
   PubMed Web of Science ®Google Scholar
• KobayashiTNakataTKuzumakiTEffect of flavonoids on cell cycle progression in prostate cancer cellsCancer Lett20021761172311790449
   PubMed Web of Science ®Google Scholar
• CaiXYeTLiuCLuteolin induced G2 phase cell cycle arrest and apoptosis on non-small cell lung cancer cellsToxicol In vitro20112571385139121601631
   PubMed Web of Science ®Google Scholar
• LiYMPanYWeiYUpregulation of CXCR4 is essential for HER2-mediated tumor metastasisCancer Cell20046545946915542430
   PubMed Web of Science ®Google Scholar
• RossJSSlodkowskaEASymmansWFPusztaiLRavdinPMHortobagyiGNThe HER-2 receptor and breast cancer: ten years of targeted anti–HER-2 therapy and personalized medicineOncologist200914432036819346299
   PubMed Web of Science ®Google Scholar
• WayTDKaoMCLinJKDegradation of HER2/neu by apigenin induces apoptosis through cytochrome c release and caspase-3 activation in HER2/neu-overexpressing breast cancer cellsFEBS Lett2005579114515215620704
   PubMed Web of Science ®Google Scholar
• CatzavelosCBhattacharyaNUngYCDecreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancerNat Med1997322272309018244
   PubMed Web of Science ®Google Scholar
• ParkSHHamSKwonTHLuteolin induces cell cycle arrest and apoptosis through extrinsic and intrinsic signaling pathways in MCF-7 breast cancer cellsJ Environ Pathol Toxicol Oncol201433321923125272060
   PubMed Web of Science ®Google Scholar
• SerginaNVRauschMWangDEscape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3Nature2007445712643744117206155
   PubMed Web of Science ®Google Scholar
• YakesFMChinratanalabWRitterCAKingWSeeligSArteagaCLHerceptin-induced inhibition of phosphatidylinositol-3 kinase and Akt Is required for antibody-mediated effects on p27, cyclin D1, and antitumor actionCancer Res200262144132414112124352
   PubMed Web of Science ®Google Scholar
• ZhangLYangFHuangLLiuAZhangJLuteolin enhances the antitumor activity of lapatinib in human breast cancer cellsBiomed Res2017281149024907
   Google Scholar
• SebastianJRichardsRGWalkerMPActivation and function of the epidermal growth factor receptor and erbB-2 during mammary gland morphogenesisCell Growth Differ1998997777859751121
   PubMedGoogle Scholar
• KenneyNJBowmanAKorachKSBarrettJCSalomonDSEffect of exogenous epidermal-like growth factors on mammary gland development and differentiation in the estrogen receptor-alpha knockout (ERKO) mouseBreast Cancer Res Treat200379216117312825851
   PubMed Web of Science ®Google Scholar
• BosPDZhangXHNadalCGenes that mediate breast cancer metastasis to the brainNature200945972491005100919421193
   PubMed Web of Science ®Google Scholar
• HicksDGShortSMPrescottNLBreast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5/6, and overexpress HER2 or EGFRAm J Surg Pathol20063091097110416931954
   PubMed Web of Science ®Google Scholar
• SuiJXieKXieMInhibitory effect of luteolin on the proliferation of human breast cancer cell lines induced by epidermal growth factorSheng Li Xue Bao2016681273426915319
   PubMedGoogle Scholar
• BrombergJStat proteins and oncogenesisJ Clin Invest200210991139114211994401
   PubMed Web of Science ®Google Scholar
• DevarajanEHuangSSTAT3 as a central regulator of tumor metastasesCur Mol Med200995626633
   Web of Science ®Google Scholar
• YangMYWangCJChenNFHoWHLuFJTsengTHLuteolin enhances paclitaxel-induced apoptosis in human breast cancer MDA-MB-231 cells by blocking STAT3Chem Biol Interact2014213606824525192
   PubMed Web of Science ®Google Scholar
• NahtaRYuanLXZhangBKobayashiREstevaFJInsulin-like growth factor-I receptor/human epidermal growth factor receptor 2 heterodimerization contributes to trastuzumab resistance of breast cancer cellsCancer Res20056523111181112816322262
   PubMed Web of Science ®Google Scholar
• OliveiraSSchiffelersRStormGHenegouwenPRooversRCrosstalk between epidermal growth factor receptor-and insulin-like growth factor-1 receptor signaling: implications for cancer therapyCurr Cancer Drug Targets20099674876019754359
   PubMed Web of Science ®Google Scholar
• JonesHEGoddardLGeeJMInsulin-like growth factor-I receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cellsEndocr Relat Cancer200411479381415613453
   PubMed Web of Science ®Google Scholar
• WangLMXieKPHuoHNShangFZouWXieMJLuteolin inhibits proliferation induced by IGF-1 pathway dependent ERα in human breast cancer MCF-7 cellsAsian Pac J Cancer Prev20121341431143722799344
   PubMedGoogle Scholar
• StrömAHartmanJFosterJSKietzSWimalasenaJGustafssonJAEstrogen receptor β inhibits 17β-estradiol-stimulated proliferation of the breast cancer cell line T47DProc Natl Acad Sci U S A200410161566157114745018
   PubMed Web of Science ®Google Scholar
• CovaledaAMvan den BergHVervoortJInfluence of cellular ERα/ERβ ratio on the ERα-agonist induced proliferation of human T47D breast cancer cellsToxicol Sci2008105230331118644836
   PubMed Web of Science ®Google Scholar
• MarkaverichBMRobertsRRAlejandroMAJohnsonGAMiddleditchBSClarkJHBioflavonoid interaction with rat uterine type II binding sites and cell growth inhibitionJ Steroid Biochem1988301–671783386279
   PubMedGoogle Scholar
• Le BailJCVarnatFNicolasJCHabriouxGEstrogenic and antiproliferative activities on MCF-7 human breast cancer cells by flavonoidsCancer Lett199813012092169751276
   PubMed Web of Science ®Google Scholar
• MarkaverichBMShoularsKRodriguezMALuteolin regulation of estrogen signaling and cell cycle pathway genes in MCF-7 human breast cancer cellsInt J Biomed Sci20117210111121731475
   PubMedGoogle Scholar
• ElmoreSApoptosis: a review of programmed cell deathToxicol Pathol200735449551617562483
   PubMed Web of Science ®Google Scholar
• SatoYSasakiNSaitoMEndoNKugawaFUenoALuteolin attenuates doxorubicin-induced cytotoxicity to mcf-7 human breast cancer cellsBiol Pharm Bul2015385703709
   Web of Science ®Google Scholar
• Rice-EvansCAMillerNJPagangaGStructure-antioxidant activity relationships of flavonoids and phenolic acidsFree Radic Biol Med19962079339568743980
   PubMed Web of Science ®Google Scholar
• JuWWangXShiHChenWBelinskySALinYA critical role of luteolin-induced reactive oxygen species in blockage of tumor necrosis factor-activated nuclear factor-κB pathway and sensitization of apoptosis in lung cancer cellsMol Pharmacol20077151381138817296806
   PubMed Web of Science ®Google Scholar
• LinCHChangCYLeeKRLinHJChenTHWanLFlavones inhibit breast cancer proliferation through the Akt/FOXO3a signaling pathwayBMC Cancer20151595826675309
   PubMed Web of Science ®Google Scholar
• Momtazi-BorojeniAABehbahaniMSadeghi-AliabadiHAntiproliferative activity and apoptosis induction of crude extract and fractions of Avicennia marinaIran J Basic Med Sci201316111203120824494074
   PubMed Web of Science ®Google Scholar
• AllredDCClarkGMElledgeRAssociation of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancerJ Natl Cancer Inst19938532002068423624
   PubMed Web of Science ®Google Scholar
• SjögrenSInganäsMNorbergTThe p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistryJ Natl Cancer Inst1996883–41731828632491
   PubMedGoogle Scholar
• JeonYWSuhYJSynergistic apoptotic effect of celecoxib and luteolin on breast cancer cellsOncol Rep201329281982523229294
   PubMed Web of Science ®Google Scholar
• DasTSumanSAlatassiHAnkemMDamodaranCInhibition of AKT promotes FOXO3a-dependent apoptosis in prostate cancerCell Death Dis201672e211126913603
   PubMed Web of Science ®Google Scholar
• SuntersAde MattosSFStahlMFoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell linesJ Biol Chem200327850497954980514527951
   PubMed Web of Science ®Google Scholar
• PizerESJackischCWoodFDPasternackGRDavidsonNEKuhajdaFPInhibition of fatty acid synthesis induces programmed cell death in human breast cancer cellsCancer Res19965612274527478665507
   PubMed Web of Science ®Google Scholar
• BrusselmansKVrolixRVerhoevenGSwinnenJVInduction of cancer cell apoptosis by flavonoids is associated with their ability to inhibit fatty acid synthase activityJ Biol Chem200528075636564515533929
   PubMed Web of Science ®Google Scholar
• LiuJFMaYWangYDuZYShenJKPengHLReduction of lipid accumulation in HepG2 cells by luteolin is associated with activation of AMPK and mitigation of oxidative stressPhytother Res201125458859620925133
   PubMed Web of Science ®Google Scholar
• YangYAHanWFMorinPJChrestFJPizerESActivation of Fatty acid synthesis during neoplastic transformation: role of mitogen-activated protein kinase and phosphatidylinositol 3-kinaseExp Cell Res20022791809012213216
   PubMed Web of Science ®Google Scholar
• GuoDPrinsRMDangJEGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapySci Signal20092101ra8220009104
   PubMed Web of Science ®Google Scholar
• XueGHemmingsBAPKB/Akt-dependent regulation of cell motilityJ Natl Cancer Inst2013105639340423355761
   PubMedGoogle Scholar
• SosMLKokerMWeirBAPTEN loss contributes to erlotinib resistance in EGFR-mutant lung cancer by activation of Akt and EGFRCancer Res20096983256326119351834
   PubMed Web of Science ®Google Scholar
• FangJZhouQShiXlJiangBHLuteolin inhibits insulin-like growth factor 1 receptor signaling in prostate cancer cellsCarcinogenesis200728371372317065200
   PubMed Web of Science ®Google Scholar
• LeeLTHuangYTHwangJJTransinactivation of the epidermal growth factor receptor tyrosine kinase and focal adhesion kinase phosphorylation by dietary flavonoids: effect on invasive potential of human carcinoma cellsBiochem Pharmacol200467112103211415135307
   PubMed Web of Science ®Google Scholar
• ShihYLLiuHCChenCSCombination treatment with luteolin and quercetin enhances antiproliferative effects in nicotine-treated MDA-MB-231 cells by down-regulating nicotinic acetylcholine receptorsJ Agric Food Chem2009581235241
   Web of Science ®Google Scholar
• HuangYTHwangJJLeePPEffects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptorBr J Pharmacol19991285999101010556937
   PubMed Web of Science ®Google Scholar
• TuSHHoCTLiuMFLuteolin sensitises drug-resistant human breast cancer cells to tamoxifen via the inhibition of cyclin E2 expressionFood Chem201314121553156123790951
   PubMed Web of Science ®Google Scholar
• van ZandenJJGeraetsLWortelboerHMvan BladerenPJRietjensIMCnubbenNHStructural requirements for the flavonoid-mediated modulation of glutathione S-transferase P1-1 and GS-X pump activity in MCF7 breast cancer cellsBiochem Pharmacol20046781607161715041478
   PubMed Web of Science ®Google Scholar
• ColemanDTBigelowRCardelliJAInhibition of fatty acid synthase by luteolin post-transcriptionally down-regulates c-Met expression independent of proteosomal/lysosomal degradationMol Cancer Ther20098121422419139131
   PubMed Web of Science ®Google Scholar
• KimMJWooJSKwonCHKimJHKimYKKimKHLuteolin induces apoptotic cell death through AIF nuclear translocation mediated by activation of ERK and p38 in human breast cancer cell linesCell Biol Int201236433934422073986
   PubMed Web of Science ®Google Scholar
• DuGJSongZHLinHHHanXFZhangSYangYMLuteolin as a glycolysis inhibitor offers superior efficacy and lesser toxicity of doxorubicin in breast cancer cellsBiochem Biophys Res Commun2008372349750218503759
   PubMed Web of Science ®Google Scholar